Bausch + Lomb Corporation
General ticker "BLCO" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $5.2B (TTM average)
Bausch + Lomb Corporation follows the US Stock Market performance with the rate: 53.1%.
Estimated limits based on current volatility of 1.3%: low 17.19$, high 17.64$
Factors to consider:
- Total employees count: 13500 as of 2024
- Top business risk factors: Market competition, Labor/talent shortage/retention, Acquisition/divestiture risks, Geopolitical risks, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [13.99$, 22.01$]
- 2025-12-31 to 2026-12-31 estimated range: [14.64$, 22.83$]
Financial Metrics affecting the BLCO estimates:
- Positive: with PPE of 29.0 at the end of fiscal year the price was neutral
- Positive: -5.02 < Operating profit margin, % of 3.41
- Negative: Industry operating cash flow per share per price (median), % of 1.00 <= 5.42
- Positive: -9.48 < Industry operating profit margin (median), % of -6.69
- Positive: 42.53 < Shareholder equity ratio, % of 48.06 <= 64.17
- Negative: Investing cash flow per share per price, % of -6.51 <= -4.41
Short-term BLCO quotes
Long-term BLCO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3,755.00MM | $4,072.00MM | $4,747.00MM |
| Operating Expenses | $3,548.00MM | $3,942.00MM | $4,585.00MM |
| Operating Income | $207.00MM | $130.00MM | $162.00MM |
| Non-Operating Income | $-134.00MM | $-296.00MM | $-396.00MM |
| Interest Expense | $146.00MM | $283.00MM | $399.00MM |
| R&D Expense | $307.00MM | $324.00MM | $343.00MM |
| Income(Loss) | $73.00MM | $-166.00MM | $-234.00MM |
| Taxes | $58.00MM | $82.00MM | $71.00MM |
| Profit(Loss)* | $6.00MM | $-260.00MM | $-317.00MM |
| Stockholders Equity | $7,033.00MM | $6,850.00MM | $6,473.00MM |
| Inventory | $628.00MM | $1,028.00MM | $1,036.00MM |
| Assets | $11,144.00MM | $13,442.00MM | $13,469.00MM |
| Operating Cash Flow | $345.00MM | $-17.00MM | $232.00MM |
| Capital expenditure | $175.00MM | $181.00MM | $291.00MM |
| Investing Cash Flow | $-215.00MM | $-2,109.00MM | $-412.00MM |
| Financing Cash Flow | $81.00MM | $2,078.00MM | $178.00MM |
| Earnings Per Share** | $0.02 | $-0.74 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.